Perrigo To Develop New Products With Bentley
This article was originally published in The Tan Sheet
Executive Summary
Bentley's development and distribution deal with Perrigo for new formulations of current products gives the company a solid foray into the U.S. specialty pharmaceuticals market with a proven sales force
You may also be interested in...
Perrigo Moves In On Major Generic Firms With Agis Acquisition
Perrigo's acquisition of Israeli generic drug firm Agis Pharmaceuticals will put the combined entity's annualized sales over the $1 bil. mark and in the same league with major Rx generic drug players
Rx Or OTC Statins May Be Springboard For Perrigo Generics Unit
Perrigo is looking into developing its own line of private label statin drugs
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC